发明名称 Treatment of Patients Suffering from Cancer
摘要 The invention relates to (among other things) a method comprising the steps of (a) administering to a patient a topoisomerase II-inhibiting amount of a long-acting topoisomerase II inhibitor; and (b) administering to the patient a topoisomerase I-inhibiting amount of a long-acting topoisomerase I inhibitor.
申请公布号 US2014378404(A1) 申请公布日期 2014.12.25
申请号 US201214354080 申请日期 2012.10.25
申请人 Nektar Therapeutics 发明人 Hoch Ute;Eldon Michael A.;Leung Abraham C.F.
分类号 A61K31/704;A61K47/48;A61K31/4745 主分类号 A61K31/704
代理机构 代理人
主权项 1. A method comprising the steps of: (a) administering to a patient a topoisomerase II-inhibiting amount of a long-acting topoisomerase II inhibitor; and (b) administering to the patient a topoisomerase I-inhibiting amount of a long-acting topoisomerase I inhibitor.
地址 San Francisco CA US